Vindon Healthcare Share Discussion Threads

[piedro] 03/5/2013 13:43

Annual Report now available from Vindonhealthcare

[piedro] 26/4/2013 15:31

Vindon CA
INTERPHEX 2013



Vindon California will be Intephex Booth #1264 which will feature a Vindon walk-in room with integral LED lighting and showcase Vindon's new smart controller, an interactive digital control system with a touch screen panel which is designed to keep users fully informed at every stage of the storage process.
The Smart Controller features Vindon's new user-friendly Windows application, which monitors and controls environment data for all Vindon stability storage cabinets, chambers, walk-in rooms and reach-in rooms. In addition service calibration and validation periods can be programmed into the system.
Patrick Jackson, Vindon Business Development Director will be in attendance for the duration of the expo, promoting Vindon's exciting new business partnership proposals which include:
• Managed facilities
• Collaborations
• Investment partnerships in emerging technologies
• Joint ventures
You will also have an opportunity to meet California Operations Manager Lindsay Haney who will be on hand to discuss any of your enquiries about the new California facility.

[piedro] 09/4/2013 16:19

More stuff ...

Santa Fe Springs is just outside Los Angeles

--------------------------------------------
... and other Oristem USA partner

Moraga Biotechnology Corporation
Based in Los Angeles California, Moraga Biotech is worldwide patent partner to the Pharmacells™ extraction technology. The main scientists behind the discovery of blastomere-like stem cells (BLSCs) are board members and full time research staff within Moraga Biotech and they are constantly striving to push forward the applications for 'our' cell line.
They are experts in their field with many years of top level research and academia behind them.
Their Californian facility is fully equipped to perform the patented process for any client based in the USA or Canada.

--------------------------------------------

in the USA or Canada ... and VindonCA.com

[piedro] 09/4/2013 15:36

Certainly quite a bit in the press with ...

Vindon Scientific are Going West!




Outsourcing Storage Demand Drives Vindon Scientific Investments
Vindon says its investments in its Irish and Californian facilities come as pharma companies shift to outsourcing stability storage in order to save costs.


Vindon Ireland Expands Pharmaceutical and Biopharma Storage Operations
... Practically all of the major pharmaceutical companies are aware their revenues may decrease because of patent expiration, fragile pipelines and the rise of generics, with the result that Pharmaceutical companies are now actively seeking alliances with trusted outsourced service partners....

[piedro] 09/4/2013 15:11

Another website, ... for California

[piedro] 09/4/2013 14:50

Special offer on US website:

Vindon News - Environmental Chambers that won't cost the Earth
We've cut the price of our low energy Environmental Chambers. Until the End of April 2013 you can pick up a Vindon 5799 or 5804 Environmental Chamber at a very special price!



30ft3 5799-S only $16,500 including delivery
And if you need more volume you can have 50% extra free!
45ft3 5804-S also $16,500 including delivery

[piedro] 02/4/2013 15:17

Shareholdings

DIRECTORS
Richard Ian Hughes......... 15,200,349.... 17.1%
Martin Liam Ferguson........ 4,150,000.... 04.7%
Thomas Patrick Jackson...... 3,000,000.... 03.4%
Martin Henry Burrill.......... 300,000.... 00.3%

OTHERS - over 3%
Ian William Currie......... 15,200,349.... 17.1%
Newedge Group SA............ 6,595,000.... 07.4%
Bank of New York............ 4,750,000.... 05.4%
John Geoffrey Bolitho....... 3,700,000.... 04.2%
Richard Leslie Matthewman... 3,377,855.... 03.8%

ALSO - not mentioned on website!
Helium Special Situations... 6,445,000.... 07.3%

[bonzo] 02/4/2013 09:58

Reduced capex and maintenance is the key, these facilities are expensive to build and maintain. I have not done a head to head comparison against the competition, the barriers to entry are significant but the world is very cost focused and their margins will be under pressure (as you can see from the results).

This work is not likely to brought back in house because of the capital costs. Equally, GSK et al are not likely to outsource it on a large scale to maintain control of their development process. The outsourcing model works best with small and medium size companies who cannot get economies of scale.

[woodcutter] 28/3/2013 16:01

Thx Bonzo

I'll wait 'til the spread gets sensible and give it some more thought.

How does their product compare to their competition on quality and price. Have you installed many of their systems. Forgive my questions but i think it's got decent long term investment potential provided i can be convinced about the barriers to entry.

Have you knowledge of the general trend in this sector. I'd read recently that many companies were bringing this type of work back in house rather than outsourcing.

My view fwiw is outsourcing seems most sensible for large players as it reduces capex, why build and pay staff costs etc when you can rent/lease?

i noticed helium have invested heavily recently and i respect them they are in UFG another stock i'm researching at present.

Woody

[bonzo] 27/3/2013 16:20

Vindon are by far the longest established experts in the area, trusted and used by most of the major companies. Barriers to entry - the length of time it takes to establish a reputation. I place contracts of this type and would only use Vindon. The normal test duration is 5 years and you don't the contractor to either go belly up or screw up your study.

However, this is not 10 bagger in the next year! just depends on your time frame.

[woodcutter] 27/3/2013 15:29

thought deeply about buying given the quality of results in particular the strength of the outlook statement and the new CA facility, but held off. Can't see any barriers to entry.........no moat! and the mm spread is riduculous.

P you've been here a long time, posted many times and very good quality too.

Barriers to entry any views?

WC

[piedro] 27/3/2013 14:40

... and here's another

Stability Testing and Storage
Comprehensive ICH stability services for pharmaceuticals and biopharmaceuticals with a full range of conditions for ICH storage stability and accelerated stability testing.
Intertek offers cGMP stability testing and storage programs for a wide range of pharmaceuticals (including biologics / biosimilars - see below) and related healthcare products to meet ICH guidelines, in addition to providing specialized non-standard conditions. Comprehensive analytical method development and validation capabilities support testing of API's, clinical trial materials (CTM's), finished products, medical devices and compatibility of formulation components.
Intertek's on-site storage stability facilities are located in Whitehouse, NJ (USA), Athlone (Ireland), PROBE (Australia) and Manchester, (UK). These laboratories meet the relevant national and international regulations from FDA, MHRA, EMEA, TGA, Health Canada etc. ...

[piedro] 27/3/2013 14:33

Competition in Ireland

Waterford-based pharmaceutical stability storage business Q1 Scientific has announced the creation of 10 new jobs for the south-east at the launch of its new Irish operations.
02.03.2013
Q1 Scientific was established to provide a world-class environmentally controlled storage facility that services the pharmaceutical, medical-device and life-sciences industries.
It is the first company in Ireland to specialise in the provision of a stability storage and quality validation service that meets the highest-international standards, as required for such highly-regulated industries. ...

[piedro] 27/3/2013 13:42

Ireland and the US pharmaceutical industry
By Barry O'Leary

[piedro] 27/3/2013 13:14

Chart - revenues - Goods vs Services



... presumably their 'niche' will be in 'services'

[piedro] 27/3/2013 12:21

this is very long "play"

What's your timescale?

It would seem that the near future is in the US
They seem to have made plenty of 'buddies' in Ireland

[piedro] 27/3/2013 11:23

Now have photo up on the US website

Vindon News - Vindon to open new facility in California mid 2013


Vindon Scientific (USA) Inc. have commenced manufacture of the controlled environment storage rooms and chambers to equip its latest storage facility ....

[bonzo] 26/3/2013 16:17

I agree, but this is very long "play", having bought at around 15p it will be a year or two before I can cover costs! Building a business is extremely hard...

[piedro] 26/3/2013 09:51

Looks good - IMO

[piedro] 26/3/2013 09:48

Preliminary Results:
- Revenue up despite competition.
- Expansion in USA + "identification of new opportunities"
- Looking for suitable acquisitions - nothing new
- Relying on reputation

[piedro] 11/3/2013 15:57

Vindon News
Vindon to open new facility in California mid 2013
Vindon Scientific (USA) Inc. have commenced manufacture of the controlled environment storage rooms and chambers to equip its latest storage facility in a move that forms part of Vindon's recent drive to expand its pharmaceutical and biopharma storage operations.
Vindon's newest facility, located in California, USA adds to its existing U.S facility in Atlanta, Georgia as it seeks to meet the product storage, testing and integrity needs of it's U.S. clients.
The new facility, in Santa Fe Springs, CA is primarily to be used for controlled environment storage of pharmaceuticals and biopharmaceuticals, tissue and cells. The storage suite will be equipped with stability chambers to provide controlled environmental conditions including temperature and humidity as specified in the ICH/WHO guidelines as well as unique conditions for clients. In addition DEA schedule I-V storage will be available as will -5ºC, -20ºC, -70ºC and –80ºC biostorage.
Vindon, a recognised world leader in controlled environment storage services and equipment has invested heavily in the new storage facility, which is scheduled for completion by mid 2013.
Vindon Scientific (USA) Inc. will also provide full logistics support from their California base to ensure clients receive a comprehensive and complete service.
Vindon's move in investing in this new facility on the West Coast of America comes as demand for Pharma and Biopharm storage services increases. And with the current US pharmaceutical market currently estimated at US$360 billion, the need for controlled environment storage and Vindon's services has never been greater.
"This investment is an investment in our partnership with our U.S. customers," said Patrick Jackson, Vindon Business Development Director.
"The facility will broaden our operational base in the USA and underscores our dedication to retaining our global reputation," he added.

[piedro] 11/3/2013 15:48

No RNS but it's on their US website ...

[piedro] 12/2/2013 09:10

To recap on past performance ...



- H2 UK usually better than H-1
- Ireland and US not significant

[piedro] 11/2/2013 08:27

RNS Number : 5355X
11 February 2013
Notice of Preliminary Results 26 March 2013
Vindon (AIM:VDN), which provides controlled environment services and products to the pharmaceutical, life sciences, food and heritage sectors in the UK, Ireland, Europe and North America, will announce its preliminary results for the year ending 31 December 2012 on Tuesday, 26 March 2013.
On the day the Group will hold a presentation at:
Venue: WH Ireland, 24 Martin Lane, London, EC4R 0DR
Time: 12.30pm
In addition, the Group will be holding a presentation on the following day, Wednesday, 27 March 2013, at the Group's main office:
Venue: John Boyd Dunlop Drive, Kingsway Business Park, Rochdale OL16 4NG
Time: 12.00pm for 12.15pm

[piedro] 06/12/2012 13:24

Drug Makers and Universities team up on €56 million adult stem cell project.
6th December 2012
Ten drug companies and 23 universities are banding together to create one of the world's largest repositories of adult stem cells, which they aim to use to develop new drugs for difficult-to-treat diseases such as dementia and diabetes.
Roche Holding AG and Oxford University are leading the €56 million, or about $73 million, project, called StemBANCC, with funding from the European Commission, industry and others. ... ...


... who gets the storage?